Frank Xiaoqing Liu

Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States

Min Huang, Yanyan Lou, James M. Pellissier et al. · PharmacoEconomics · 2017 · 148 citations · Full text

Medicine, Pharmacology, Metastatic Nsclc +7

Real-world PD-L1 testing and distribution of PD-L1 tumor expression by immunohistochemistry assay type among patients with metastatic non-small cell lung cancer in the United States

Vamsidhar Velcheti, Pallavi Patwardhan, Frank Xiaoqing Liu et al. · PLoS ONE · 2018 · 69 citations · Full text

Bloodstream Infections Associated With Parenteral Nutrition Preparation Methods in the United States

Robin S. Turpin, Todd W. Canada, Víctor Rosenthal et al. · Journal of Parenteral and Enteral Nutrition · 2011 · 66 citations

Economic Evaluation of Urgent-Start Peritoneal Dialysis Versus Urgent-Start Hemodialysis in the United States

Frank Xiaoqing Liu, Arshia Ghaffari, Harman Dhatt et al. · Medicine · 2014 · 65 citations · Full text

Dialysis Therapy, Cost Model, United States +18

Peritoneal Dialysis and In-Centre Haemodialysis: A Cost-Utility Analysis from a UK Payer Perspective

Catrin Treharne, Frank Xiaoqing Liu, Lydia Crowe et al. · Applied Health Economics and Health Policy · 2014 · 63 citations · Full text